Size-tunable strategies for a tumor targeted drug delivery system
W Yu, R Liu, Y Zhou, H Gao - ACS central science, 2020 - ACS Publications
Nanoparticles have been widely used in tumor targeted drug delivery, while the antitumor
effects are not always satisfactory due to the limited penetration and retention. As we all …
effects are not always satisfactory due to the limited penetration and retention. As we all …
Bioresponsive drug delivery systems for the treatment of inflammatory diseases
Y Dou, C Li, L Li, J Guo, J Zhang - Journal of Controlled Release, 2020 - Elsevier
Inflammation is intimately related to the pathogenesis of numerous acute and chronic
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
diseases like cardiovascular disease, inflammatory bowel disease, rheumatoid arthritis, and …
A thrombin‐activated peptide‐templated nanozyme for remedying ischemic stroke via thrombolytic and neuroprotective actions
Ischemic stroke (IS) is one of the most common causes of disability and death. Thrombolysis
and neuroprotection are two current major therapeutic strategies to overcome ischemic and …
and neuroprotection are two current major therapeutic strategies to overcome ischemic and …
Shell-sheddable polymeric micelles alleviate oxidative stress and inflammation for enhanced ischemic stroke therapy
Z Wang, J Pan, R Yuan, M Chen, X Guo, S Zhou - Nano Letters, 2023 - ACS Publications
As a ROS scavenger, resveratrol exerts a neuroprotective effect by polarizing the M1
microglia to the anti-inflammatory M2 phenotype for ischemic stroke treatment. However, the …
microglia to the anti-inflammatory M2 phenotype for ischemic stroke treatment. However, the …
Targeted treatment of ischemic stroke by bioactive nanoparticle-derived reactive oxygen species responsive and inflammation-resolving nanotherapies
J Yuan, L Li, Q Yang, H Ran, J Wang, K Hu, W Pu… - ACS …, 2021 - ACS Publications
Stroke is a primary cause of death and disability worldwide, while effective and safe drugs
remain to be developed for its clinical treatment. Herein, we report bioactive nanoparticle …
remain to be developed for its clinical treatment. Herein, we report bioactive nanoparticle …
Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies
J Liao, L Fan, Y Li, QQ Xu, LY Xiong, SS Zhang… - Journal of Controlled …, 2023 - Elsevier
In recent years, brain diseases have seriously threatened human health due to their high
morbidity and mortality. Achieving efficient drug delivery to provide satisfactory therapeutic …
morbidity and mortality. Achieving efficient drug delivery to provide satisfactory therapeutic …
Preferential targeting cerebral ischemic lesions with cancer cell-inspired nanovehicle for ischemic stroke treatment
W He, Q Mei, J Li, Y Zhai, Y Chen, R Wang, E Lu… - Nano Letters, 2021 - ACS Publications
The poor drug delivery to cerebral ischemic regions is a key challenge of ischemic stroke
treatment. Inspired by the intriguing blood–brain barrier (BBB)-penetrating ability of 4T1 …
treatment. Inspired by the intriguing blood–brain barrier (BBB)-penetrating ability of 4T1 …
Bioactive ceria nanoenzymes target mitochondria in reperfusion injury to treat ischemic stroke
J Liao, Y Li, L Fan, Y Sun, Z Gu, QQ Xu, Y Wang… - ACS …, 2024 - ACS Publications
Overproduction of reactive oxygen species by damaged mitochondria after ischemia is a key
factor in the subsequent cascade of damage. Delivery of therapeutic agents to the …
factor in the subsequent cascade of damage. Delivery of therapeutic agents to the …
[HTML][HTML] Recent advances in nanomedicines for the treatment of ischemic stroke
C Li, T Sun, C Jiang - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Ischemic stroke is a cerebrovascular disease normally caused by interrupted blood supply to
the brain. Ischemia would initiate the cascade reaction consisted of multiple biochemical …
the brain. Ischemia would initiate the cascade reaction consisted of multiple biochemical …
Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection
W Yu, N Yin, Y Yang, C Xuan, X Liu, W Liu, Z Zhang… - Acta biomaterialia, 2022 - Elsevier
Rational design of nanomedicine to accelerate thrombolysis and sequentially avoid
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …
thrombolysis-mediated reperfusion injury is still a challenge. Here, we develop a biomimetic …